Alicia Goodman
Human Resources Officer en CERUS CORPORATION .
Perfil
Alicia Goodman is currently the Chief Human Resources Officer at Cerus Corp.
Prior to this, she was the Senior Vice President of Human Resources at Aimmune Therapeutics, Inc. from 2019 to 2023.
She also served as the Vice President of Human Resources at Novartis AG and the Senior VP, Chief People & Culture Officer at Berg LLC.
Ms. Goodman received her undergraduate degree from Michigan State University and her graduate degree from Central Michigan University.
Cargos activos de Alicia Goodman
Empresas | Cargo | Inicio |
---|---|---|
CERUS CORPORATION | Human Resources Officer | 27/09/2023 |
Antiguos cargos conocidos de Alicia Goodman.
Empresas | Cargo | Fin |
---|---|---|
AIMMUNE THERAPEUTICS, INC. | Human Resources Officer | 01/02/2023 |
NOVARTIS AG | Human Resources Officer | - |
Berg LLC
Berg LLC Pharmaceuticals: MajorHealth Technology Berg LLC operates as a biopharmaceutical company, which focuses on taking a bold back to biology approach to therapeutic discovery using its Interrogative Biology platform. Its therapeutics include cancer metabolism and BPM 31510, chemotherapy induced alopecia and BPM 315453, neurology-discovery program, and metabolic disease-discovery program. The company was founded by Carl Edwin Berg, Mitch Gray, and Niven R. Narain in 2006 and is headquartered in Framingham, MA. | Human Resources Officer | - |
Formación de Alicia Goodman.
Michigan State University | Undergraduate Degree |
Central Michigan University | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
CERUS CORPORATION | Health Technology |
NOVARTIS AG | Health Technology |
Empresas privadas | 2 |
---|---|
Aimmune Therapeutics, Inc.
Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
Berg LLC
Berg LLC Pharmaceuticals: MajorHealth Technology Berg LLC operates as a biopharmaceutical company, which focuses on taking a bold back to biology approach to therapeutic discovery using its Interrogative Biology platform. Its therapeutics include cancer metabolism and BPM 31510, chemotherapy induced alopecia and BPM 315453, neurology-discovery program, and metabolic disease-discovery program. The company was founded by Carl Edwin Berg, Mitch Gray, and Niven R. Narain in 2006 and is headquartered in Framingham, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Alicia Goodman